Circadian Technologies Limited Share Price Australian S.E.
Equities
AU000000CIR6
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- AUD | - |
04-03 | Opthea Limited Announces Board Changes | CI |
02-29 | Opthea Posts H1 FY24 Loss per Share of $0.1623; R&D Expenses Jump | MT |
Sales 2024 * | 922K 617K 48.58M | Sales 2025 * | 17.45M 11.68M 920M | Capitalization | 418M 279M 22B |
---|---|---|---|---|---|
Net income 2024 * | -278M -186M -14.65B | Net income 2025 * | -224M -150M -11.8B | EV / Sales 2024 * | 620 x |
Net Debt 2024 * | 154M 103M 8.1B | Net Debt 2025 * | 212M 142M 11.16B | EV / Sales 2025 * | 36.1 x |
P/E ratio 2024 * |
-1.38
x | P/E ratio 2025 * |
-1.96
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.31% |
Managers | Title | Age | Since |
---|---|---|---|
Frédéric Guerard
CEO | Chief Executive Officer | 51 | 26/10/23 |
Megan Baldwin
FOU | Founder | 49 | 31/12/07 |
Peter F. Lang
DFI | Director of Finance/CFO | 52 | 26/10/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CHM | Chairman | 70 | 04/10/20 |
Quinton Oswald
BRD | Director/Board Member | - | 20/04/22 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 23/07/20 |
1st Jan change | Capi. | |
---|---|---|
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |